Managerial and Decision Economics

1997 - 2009

Edited by Paul H. Rubin

from John Wiley & Sons, Ltd.
Series data maintained by Christopher F. Baum ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 28, issue 8, 2007

Trust and formal contracts in interorganizational relationships - substitutes and complements pp. 833-847

Thomas Mellewigt, Anoop Madhok and Antoinette Weibel

Contests with investment pp. 849-862

Johannes Münster

Corporate investments and growth options pp. 863-877

Jeffrey J. Reuer and Tony W. Tong

Corporate governance and the returns to acquiring firms' shareholders: an international comparison pp. 879-896

Dennis C. Mueller and B. Burcin Yurtoglu

Bargaining over managerial contracts in delegation games: managerial power, contract disclosure and cartel behavior pp. 897-904

Arjen van Witteloostuijn, Thijs Jansen and Arie van Lier

Volume 28, issue 7, 2007

Price rigidity and flexibility: new empirical evidence pp. 639-647

Daniel Levy

Small price changes and menu costs pp. 649-656

Saul Lach and Daniel Tsiddon

The mechanics of price adjustment: new evidence on the (un)importance of menu costs pp. 657-668

Rajesh Chakrabarti and Barry Scholnick

Thick markets, market competition and pricing dynamics: evidence from retailers pp. 669-677

Kostas Axarloglou

Follow the leader: price change timing in Internet-based selling pp. 679-700

Robert J. Kauffman and Charles A. Wood

Why do prices rise faster than they fall? With an application to mortgage rates pp. 701-712

Linda A. Toolsema and Jan Jacobs

The dynamics of daily retail gasoline prices pp. 713-722

Michael C Davis

Asymmetric price adjustment: evidence from weekly product-level scanner price data pp. 723-736

Georg Müller and Sourav Ray

Price rigidity and market power in German retailing pp. 737-749

Sascha A. Weber and Sven M. Anders

The frequency and size of price adjustment: microeconomic evidence pp. 751-762

Attila Rátfai

Retail prices during a change in monetary regimes: evidence from Sears, Roebuck catalogs, 1938-1951 pp. 763-775

Andrew T. Young and Alexander K. Blue

Are they always offering the lowest price? An empirical analysis of the persistence of price dispersion in a low inflation environment pp. 777-788

Sebnem Bahadir-Lust, Jens-Peter Loy and Christoph R. Weiss

Price variability and price dispersion in a stable monetary environment: evidence from German retail markets pp. 789-801

Matthias R. Fengler and Joachim Winter

Hierarchical delays as a source of nominal price rigidities: evidence from the microcomputer industry pp. 803-815

Michael J. Hicks

Non-price rigidity and cost of adjustment pp. 817-832

Georg Müller, Mark Bergen, Shantanu Dutta and Daniel Levy

Volume 28, issue 6, 2007

Price rigidity and flexibility: recent theoretical developments pp. 523-530

Daniel Levy

The frequency and costs of individual price adjustment pp. 531-552

Alexander L. Wolman

A sociological view of costs of price adjustment: contributions from grounded theory methods pp. 553-567

Mark J. Zbaracki

Optimal price promotion in the presence of asymmetric reference-price effects pp. 569-577

Gadi Fibich, Arieh Gavious and Oded Lowengart

Production, inventory and waiting time pp. 579-589

Gil S. Epstein

Costly price adjustment and the optimal rate of inflation pp. 591-603

Jerzy D. Konieczny

Explaining hump-shaped inflation responses to monetary policy shocks pp. 605-617

James Yetman

Price rigidities, inventories, and growth fluctuations pp. 619-631

Dr. Christopher Tsoukis and Naveed Naqvi

The real effects of inflation in continuous versus discrete time sticky price models pp. 633-638

Wai-Yip Alex Ho and James Yetman

Volume 28, issue 4-5, 2007

Editorial pp. 229-229

John A. Vernon and Richard L Manning

Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion pp. 231-250

Ernst R. Berndt, Patricia M. Danzon and Gregory B. Kruse

'Branded Generics' as a strategy to limit cannibalization of pharmaceutical markets pp. 251-265

David Reiffen and Michael R. Ward

Uncertainty and choice: the challenges of pharmaceutical efficacy, safety, and cost pp. 267-283

F.M. Scherer

Commentary pp. 285-291

Joseph A. DiMasi

The cost of US pharmaceutical price regulation: a financial simulation model of R&D decisions pp. 293-306

Thomas A. Abbott and John A. Vernon

Mergers and acquisitions in the pharmaceutical and biotech industries pp. 307-328

Patricia M. Danzon, Andrew Epstein and Sean Nicholson

Effects of profit-reducing policies on firm survival, financial performance, and new drug introductions in the research-based pharmaceutical industry pp. 329-351

Darren Filson and Neal A. Masia

Commentary pp. 353-355

Joseph Golec

Determinants of drug prices and expenditures pp. 357-370

William S. Comanor and Stuart O. Schweitzer

Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as 'Equipment for Your Health' pp. 371-392

Frank Lichtenberg and Suchin Virabhak

An industrial organization perspective on the influenza vaccine shortage pp. 393-405

F.M. Scherer

Drug and vaccine pricing and innovation: what is the story? pp. 407-413

Mark V. Pauly

A primer on the economics of re-importation of prescription drugs pp. 415-435

Ernst R. Berndt

Commentary pp. 437-438

Tomas Philipson

Entry and competition in generic biologics pp. 439-451

Henry G. Grabowski, David B. Ridley and Kevin A. Schulman

Commentary pp. 453-454

Tomas Philipson

Product differentiation, competition and regulation of new drugs: the case of statins in four European countries pp. 455-465

Panos Kanavos, Joan Costa-i-Font and Alistair McGuire

Commentary pp. 467-468

Tomas Philipson

The cost of biopharmaceutical R&D: is biotech different? pp. 469-479

Joseph A. DiMasi and Henry G. Grabowski

New estimates of pharmaceutical research and development spending by US-based firms from 1984 to 2003 pp. 481-483

Joseph Golec and John A. Vernon

Benefits and costs of newer drugs: an update pp. 485-490

Frank Lichtenberg

Generic competition and market exclusivity periods in pharmaceuticals pp. 491-502

Henry G. Grabowski and Margaret Kyle

The role of different types of health insurance on access and utilization: comparative results on two chronic conditions (hypertension and diabetes type II without complication) pp. 503-507

Christine Huttin

Rx Roulette: combatting counterfeit pharmaceuticals in developing nations pp. 509-520

Kristina M. Lybecker

The truth about the drug companies, by Marcia Angell, Random House: New York, 2004. xx +305 pp., $24.95 pp. 521-522

F.M. Scherer

Volume 28, issue 3, 2007

Do stable strategic time periods exist? Towards new methodological and theoretical insights pp. 171-180

Juan Manuel de la Fuente-Sabaté, Julio Rodríguez-Puerta, José David Vicente-Lorente and José Angel Zúñiga-Vicente

Organisational susceptibility to fraud and theft, organizational size and the effectiveness of management controls: some UK evidence pp. 181-193

Paul Barnes and Jill Webb

Managerial expertise, learning potential and dynamic incentives: get more for less? pp. 195-211

Christian Lukas

New Institutional Economics' contribution to strategic groups analysis pp. 213-228

Stephane Tywoniak, Peter Galvin and Jennifer Davies

Volume 28, issue 2, 2007

The strategic use of managerial incentives in a non-profit firm mixed duopoly pp. 83-91

greg Goering

If you play well they will come-and vice versa: bidirectional causality in major-league baseball pp. 93-105

Ira Horowitz

Investment in organizational capital pp. 107-113

Orlando Gomes

Credible collusion in multimarket oligopoly pp. 115-128

Timothy L. Sorenson

Bank monitoring, managerial ownership and Tobin's Q: an empirical analysis for India pp. 129-143

Saibal Ghosh

Firm governance and duopoly: in weakness may lie strength pp. 145-155

Malcolm P. Brady

The paradox of inelastic sports pricing pp. 157-158

Philip K. Porter

Reply to 'the paradox of inelastic sports pricing' pp. 159-160

Rodney Fort

A further clarification of OCRA and its properties in response to Wang and Wang (2005) pp. 161-168

Celik Parkan

Notorious murders, black lanterns, & moveable goods: the transformation of Edinburgh's underworld in the early nineteenth century, by Symonds, D. A., Series on International Political and Economic History, University of Akron Press: Akron, OH; 2006, xiv+180pp., USD 39.95 (cloth) pp. 169-170

William F. Shughart

Volume 28, issue 1, 2007

Rural Internet access: over-subscription strategies, regulation and equilibrium pp. 1-12

SeungJae Shin, Martin B. Weiss and Jack Tucci

Efficient organization of information processing pp. 13-26

Jacek Cukrowski and Manfred M. Fischer

Patterns of corporate governance and technical efficiency in Italian manufacturing pp. 27-40

Sergio Destefanis and Vania Sena

Preliminary evidence on the appointment of institutional solutions to franchisor moral hazard-the case of franchisee councils pp. 41-55

Olivier Cochet and Thomas Ehrmann

Hidden monopsony rents in winner-take-all markets-sport and economic contribution of Spanish soccer players pp. 57-70

Pedro Garcia-del-Barrio and Francesc Pujol

Correction of errors in Vetschera's (2004) model of behavioral uncertainty and investment pp. 71-76

G.A. Tularam and A.S. Soomro

Response to Tularam and Soomro pp. 77-78

Rudolf Vetschera

Handbook of sports economics research, edited by Fizel, J. Armonk, NY and London: M.E. Sharpe, 2006, Viii+280pp., USD 75.95 (cloth) pp. 79-80

John Charles Bradbury

Contract theory, by Bolton, P. and Dewatripont, M. MIT Press: Cambridge and London. 2005, xvi+724 pp., USD 65.00 (cloth) pp. 81-82

Atin Basuchaudhary